AstraZeneca to cap costs of inhalers at $35 per month

Mar. 18, 2024 12:17 PM ETAstraZeneca PLC (AZN) StockGSK, NVO, LLY, SNYBy: Val Brickates Kennedy, SA News Editor
Visiting senior

milan2099/E+ via Getty Images

AstraZeneca (NASDAQ:AZN) plans to cap out-of-pocket costs for its inhaler medications at $35 per month following Congressional criticism of the company's pricing of the products in the US.

The cap, which will take effect June 1, would apply to uninsured and underinsured

Recommended For You

More Trending News

About AZN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AZN--
AstraZeneca PLC